Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose
Amid the sudden surge in COVID-19 cases due to Omicron and the need for booster doses for better protection, Biological E has been given the nod by the Drug Controller General of India (DCGI) to conduct phase 3 trials of its vaccine…
Read More...
Read More...